Filing Flows › Allarity Therapeutics (ALLR) › Recalls, complaints & regulation
Allarity Therapeutics (ALLR): clinical trials
Allarity Therapeutics (ALLR) beyond its filings: 2 active clinical trials.
Allarity Therapeutics' latest quarter
Allarity Therapeutics, Q1 2026: revenue $25K, net loss $2.8M, operating cash flow −$4.5M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Allarity Therapeutics have?
2 active studies on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.